SCHEMBL26897014

SCHEMBL26897014

CCC(C)C(F)(F)c1cnc(C)s1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MLYCD O95822 2/20 0.34
HCAR2 Q8TDS4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26858665 0.82 HCAR2 (0.34) MLYCDHCAR2
SCHEMBL26897139 0.81 HCAR2 (0.32) HCAR2
SCHEMBL26897006 0.81 HCAR2 (0.32) HCAR2
SCHEMBL12058917 0.77 HCAR2 (0.39) MLYCDHCAR2
SCHEMBL26859996 0.74 HCAR2 (0.34) MLYCDHCAR2
SCHEMBL21209899 0.71 HCAR2 (0.38) MLYCDHCAR2
SCHEMBL16996968 0.70 HCAR2 (0.36) MLYCDHCAR2
SCHEMBL21610747 0.70 HCAR2 (0.36) MLYCDHCAR2
SCHEMBL8447951 0.70 HCAR2 (0.36) MLYCDHCAR2
SCHEMBL14037127 0.69 MLYCD (0.37) MLYCDHCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230374022-A1 INHIBITORS OF PARG 858 THERAPEUTICS, INC. 2023-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230374022-A1 INHIBITORS OF PARG PARG, PLG, SERPINB1 MLYCD 2580/4885HCAR2 1982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.